Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026

Even Low HIV Load Can Double Heart Disease Risk

EU Widens Access for Rare Lipid and Obesity Disorders

Low-Dose Aspirin Underutilized as Preeclampsia Prevention

Adoption Before Evidence: CHIP-BCIS3 Humbles Impella

Medical AI Named First-Ever Recipient of ACC Global Digital Health Award at American College of Cardiology Annual Scientific Session

High Dx Yield Supports Workup for INOCA

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR